Pamela Berry

1.2k total citations
14 papers, 274 citations indexed

About

Pamela Berry is a scholar working on Molecular Biology, Infectious Diseases and Immunology. According to data from OpenAlex, Pamela Berry has authored 14 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Pamela Berry's work include Chemical Synthesis and Analysis (3 papers), HIV Research and Treatment (3 papers) and HIV/AIDS drug development and treatment (3 papers). Pamela Berry is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), HIV Research and Treatment (3 papers) and HIV/AIDS drug development and treatment (3 papers). Pamela Berry collaborates with scholars based in United States, Switzerland and China. Pamela Berry's co-authors include Yvonne R. Freund, Eric E. Easom, Robert T. Jacobs, Jacob J. Plattner, Yong-Kang Zhang, D Kertesz, David C. Swinney, Philip J. Rosenthal, Jianxin Cao and Gabrielle Heilek and has published in prestigious journals such as Nature Communications, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Pamela Berry

14 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pamela Berry United States	11	105	74	63	46	43	14	274
Alexandre S. Lawrenson United Kingdom	10	128 1.2×	87 1.2×	57 0.9×	55 1.2×	35 0.8×	11	338
Darren W. Begley United States	11	234 2.2×	32 0.4×	43 0.7×	35 0.8×	14 0.3×	19	290
Liezl Gibhard South Africa	12	99 0.9×	87 1.2×	50 0.8×	40 0.9×	25 0.6×	25	353
Jenny Legac United States	11	124 1.2×	143 1.9×	64 1.0×	38 0.8×	20 0.5×	21	314
Lars Herrmann Germany	9	129 1.2×	157 2.1×	34 0.5×	40 0.9×	11 0.3×	17	324
Michael H. L. Wong United Kingdom	7	197 1.9×	79 1.1×	49 0.8×	61 1.3×	20 0.5×	7	478
Dina Coertzen South Africa	13	109 1.0×	115 1.6×	46 0.7×	24 0.5×	14 0.3×	21	296
Isabel Zeitträger Germany	9	128 1.2×	87 1.2×	36 0.6×	146 3.2×	30 0.7×	9	401
Vijayakumar Balakrishnan India	13	88 0.8×	30 0.4×	33 0.5×	38 0.8×	12 0.3×	35	399
Steven Pratt United Kingdom	12	244 2.3×	163 2.2×	50 0.8×	60 1.3×	28 0.7×	15	473

Countries citing papers authored by Pamela Berry

Since Specialization

Citations

This map shows the geographic impact of Pamela Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Berry more than expected).

Fields of papers citing papers by Pamela Berry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Berry. The network helps show where Pamela Berry may publish in the future.

Co-authorship network of co-authors of Pamela Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Berry. A scholar is included among the top collaborators of Pamela Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Berry. Pamela Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Lunde, Christopher S., Erin E. Stebbins, Rajiv S. Jumani, et al.. (2019). Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis. Nature Communications. 10(1). 2816–2816. 44 indexed citations

Robertson, Gregory T., Michaël Scherman, Matthew B. McNeil, et al.. (2019). Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model. Antimicrobial Agents and Chemotherapy. 63(4). 11 indexed citations

Carter, David S., Robert T. Jacobs, Yvonne R. Freund, et al.. (2019). Macrofilaricidal Benzimidazole–Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked Analogs. ACS Infectious Diseases. 6(2). 180–185. 16 indexed citations

Zhang, Yong-Kang, Jacob J. Plattner, Eric E. Easom, et al.. (2017). Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate. Journal of Medicinal Chemistry. 60(13). 5889–5908. 53 indexed citations

Akama, Tsutomu, Yong-Kang Zhang, Yvonne R. Freund, et al.. (2017). Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT). Bioorganic & Medicinal Chemistry Letters. 28(1). 6–10. 33 indexed citations

Lemoine, Rémy C., Ann Petersen, Andreas Jekle, et al.. (2010). Exploration of a new series of CCR5 antagonists: Multi-dimensional optimization of a sub-series containing N-substituted pyrazoles. Bioorganic & Medicinal Chemistry Letters. 20(16). 4753–4756. 3 indexed citations

Padilla, Fernando, Surya Sankuratri, Changhua Ji, et al.. (2010). Synthesis, SAR and evaluation of [1,4′]-bipiperidinyl-4-yl-imidazolidin-2-one derivatives as novel CCR5 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(11). 3219–3222. 8 indexed citations

Wanner, Jutta, Lijing Chen, Rémy C. Lemoine, et al.. (2010). Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series. Bioorganic & Medicinal Chemistry Letters. 20(22). 6802–6807. 2 indexed citations

Trejo‐Martin, Alejandra, Eun Kyung Lee, Surya Sankuratri, et al.. (2009). Spiropiperidine CCR5 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(18). 5401–5406. 17 indexed citations

10.

Lemoine, Rémy C., Ann Petersen, Jutta Wanner, et al.. (2009). Evaluation of secondary amide replacements in a series of CCR5 antagonists as a means to increase intrinsic membrane permeability. Part 1: Optimization of gem-disubstituted azacycles. Bioorganic & Medicinal Chemistry Letters. 20(2). 704–708. 12 indexed citations

11.

Yang, Hanbiao, Fernando Padilla, Gabrielle Heilek, et al.. (2008). Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonist. Bioorganic & Medicinal Chemistry Letters. 19(1). 209–213. 11 indexed citations

12.

Fitch, William L., Pamela Berry, Ya‐Ping Tu, et al.. (2004). IDENTIFICATION OF GLUTATHIONE-DERIVED METABOLITES FROM AN IP RECEPTOR ANTAGONIST. Drug Metabolism and Disposition. 32(12). 1482–1490. 10 indexed citations

13.

Swinney, David C., et al.. (1994). Selective Inhibition of Mammalian Lanosterol 14.alpha.-Demethylase by RS-21607 in vitro and in vivo. Biochemistry. 33(15). 4702–4713. 27 indexed citations

14.

Kertesz, D, et al.. (1993). Selective inhibition of mammalian lanosterol 14.alpha.-demethylase: a possible strategy for cholesterol lowering. Journal of Medicinal Chemistry. 36(15). 2235–2237. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact